Fayez Sarofim & Co
CVS icon

Fayez Sarofim & Co’s CVS Health CVS Stock Holding History

Fayez Sarofim & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$731K Buy
7,070
+297
+4% +$26.5K ﹤0.01% 204
2026
Q1 		$486K Hold
6,773
– – ﹤0.01% 226
2025
Q4 		$538K Sell
6,773
-140
-2% -$11K ﹤0.01% 221
2025
Q3 		$521K Buy
6,913
+140
+2% +$9.6K ﹤0.01% 232
2025
Q2 		$467K Hold
6,773
– – ﹤0.01% 238
2025
Q1 		$459K Sell
6,773
-1,500
-18% -$89.8K ﹤0.01% 236
2024
Q4 		$371K Sell
8,273
-1,200
-13% -$67.3K ﹤0.01% 251
2024
Q3 		$596K Hold
9,473
– – ﹤0.01% 206
2024
Q2 		$559K Sell
9,473
-1,881
-17% -$118K ﹤0.01% 205
2024
Q1 		$906K Buy
11,354
+513
+5% +$39.2K ﹤0.01% 172
2023
Q4 		$827K Sell
10,841
-2,116
-16% -$151K ﹤0.01% 177
2023
Q3 		$905K Sell
12,957
-249
-2% -$17.6K ﹤0.01% 170
2023
Q2 		$913K Sell
13,206
-4,836
-27% -$344K ﹤0.01% 171
2023
Q1 		$1.34M Sell
18,042
-1,720
-9% -$144K ﹤0.01% 167
2022
Q4 		$1.84M Buy
19,762
+500
+3% +$48.2K 0.01% 142
2022
Q3 		$1.84M Sell
19,262
-418
-2% -$41.4K 0.01% 143
2022
Q2 		$1.82M Sell
19,680
-573
-3% -$55.9K 0.01% 149
2022
Q1 		$2.05M Sell
20,253
-4,524
-18% -$475K 0.01% 156
2021
Q4 		$2.56M Buy
24,777
+11,424
+86% +$1.06M 0.01% 150
2021
Q3 		$1.13M Sell
13,353
-11,865
-47% -$994K ﹤0.01% 182
2021
Q2 		$2.1M Buy
25,218
+17,583
+230% +$1.44M 0.01% 153
2021
Q1 		$574K Sell
7,635
-440
-5% -$32K ﹤0.01% 212
2020
Q4 		$552K Buy
8,075
+1,640
+25% +$107K ﹤0.01% 208
2020
Q3 		$376K Hold
6,435
– – ﹤0.01% 215
2020
Q2 		$418K Buy
6,435
+3,012
+88% +$190K ﹤0.01% 201
2020
Q1 		$203K Hold
3,423
– – ﹤0.01% 230
2019
Q4 		$254K Sell
3,423
-102
-3% -$7.16K ﹤0.01% 243
2019
Q3 		$222K Buy
+3,525
New +$209K ﹤0.01% 239
2019
Q2 		– Sell
-5,222
Closed -$282K – 255
2019
Q1 		$282K Sell
5,222
-2,073
-28% -$128K ﹤0.01% 222
2018
Q4 		$478K Buy
+7,295
New +$545K ﹤0.01% 180
2017
Q2 		– Sell
-3,893
Closed -$306K – 245
2017
Q1 		$306K Sell
3,893
-312
-7% -$24.9K ﹤0.01% 218
2016
Q4 		$332K Buy
4,205
+79
+2% +$6.39K ﹤0.01% 209
2016
Q3 		$367K Sell
4,126
-265
-6% -$25K ﹤0.01% 205
2016
Q2 		$420K Hold
4,391
– – ﹤0.01% 192
2016
Q1 		$455K Buy
4,391
+672
+18% +$65.3K ﹤0.01% 181
2015
Q4 		$364K Buy
3,719
+298
+9% +$29.2K ﹤0.01% 198
2015
Q3 		$330K Buy
3,421
+145
+4% +$15.2K ﹤0.01% 206
2015
Q2 		$344K Sell
3,276
-158
-5% -$16.1K ﹤0.01% 206
2015
Q1 		$354K Sell
3,434
-75
-2% -$7.59K ﹤0.01% 204
2014
Q4 		$338K Sell
3,509
-279
-7% -$24.6K ﹤0.01% 204
2014
Q3 		$301K Sell
3,788
-79
-2% -$6.23K ﹤0.01% 220
2014
Q2 		$291K Buy
3,867
+453
+13% +$34.2K ﹤0.01% 236
2014
Q1 		$256K Buy
3,414
+195
+6% +$13.8K ﹤0.01% 227
2013
Q4 		$230K Buy
+3,219
New +$207K ﹤0.01% 234

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fayez Sarofim & Co's CVS Position: Q2 2026 in Review

Fayez Sarofim & Co increased its CVS Health (CVS) stake by 4.4% in Q2 2026, buying an estimated $26.5K and bringing the position to 7,070 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #204.

Fayez Sarofim & Co first reported a position in CVS in Q4 2013 and has held it in 44 quarters since. The position peaked at $2.56M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Fayez Sarofim & Co held 7,070 shares of CVS Health worth $731K as of Q2 2026.
  • Fayez Sarofim & Co bought 297 CVS Health shares in Q2 2026, an estimated $26.5K.
  • CVS Health made up ﹤0.01% of Fayez Sarofim & Co's portfolio in Q2 2026, its #204 holding.
  • Fayez Sarofim & Co first reported a position in CVS Health in Q4 2013 and has held it in 44 quarters since.
  • Fayez Sarofim & Co's CVS Health position peaked at $2.56M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fayez Sarofim & Co's 13F filing for Q2 2026, filed 17 Aug 2026.